Form 4 Tracker
PTC THERAPEUTICS, INC.
PTCT

19 insider filings · Latest: May 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 15, 2026May 15 2:06 PMBoulding Mark Elliott
Proposed Sale
2,812$72.45$203.7K

View →

May 14, 2026May 14 7:09 PMKlein Matthew B.
Proposed Sale
2,572$72.46$186.4K

View →

May 14, 2026May 14 4:43 PMKlein Matthew B.
Proposed Sale
10,000$73.08$730.8K

View →

May 8, 2026May 12 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
3,540$78.97$279.6K105,212(D)

View →

May 8, 2026May 8 8:15 PMBoulding Mark Elliott
Proposed Sale
3,540$78.97$279.6K

View →

Apr 21, 2026Apr 23 9:20 PMMatthew B. KleinDirector, CHIEF EXECUTIVE OFFICER
Sale
2,850$70.91$202.1K394,070(D)

View →

Apr 21, 2026Apr 21 8:12 PMKlein Matthew B.
Proposed Sale
2,850$70.94$202.2K

View →

Apr 6, 2026Apr 8 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
2,265$69.45$157.3K105,212(D)

View →

Apr 2, 2026Apr 6 9:20 PMLee Scott GoldenEVP & CHIEF MEDICAL OFFICER
Sale
829$67.99$56.4K79,115(D)

View →

Apr 6, 2026Apr 6 8:13 PMBoulding Mark Elliott
Proposed Sale
2,265$69.44$157.3K

View →

Apr 1, 2026Apr 3 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Sale
52,003$69.04$3.6M60,137(D)

View →

Apr 2, 2026Apr 2 7:32 PMGolden Lee Scott
Proposed Sale
829$67.99$56.4K

View →

Apr 1, 2026Apr 1 8:46 PMAlmstead Neil Gregory
Proposed Sale
52,003$69.04$3.6M

View →

Mar 12, 2026Mar 13 9:20 PMMatthew B. KleinDirector, CHIEF EXECUTIVE OFFICER
Sale
2,662$64.08$170.6K396,920(D)

View →

Mar 10, 2026Mar 12 9:20 PMStephanie OkeyDirector
Sale
15,167$70.00$1.1M8,000(D)

View →

Mar 12, 2026Mar 12 7:23 PMKlein Matthew B.
Proposed Sale
2,662$64.08$170.6K

View →

Mar 10, 2026Mar 10 6:12 PMOkey Stephanie
Proposed Sale
15,167$70.00$1.1M

View →

Mar 5, 2026Mar 9 9:20 PMStephanie OkeyDirector
Sale
6,333$63.38$401.4K8,000(D)

View →

Mar 5, 2026Mar 9 9:20 PMLee Scott GoldenEVP & CHIEF MEDICAL OFFICER
Sale
10,000$63.38$633.8K79,944(D)

View →

Mar 5, 2026Mar 9 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Sale
3,989$63.38$252.8K2,737(I)

View →

Page 1 of 8

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 8, 2026May 12 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
3,540$46.5441,460(D)

View →

Apr 6, 2026Apr 8 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,265$39.426,798(D)

View →

Mar 24, 2026Mar 26 11:41 PMJessica Caroline ChutterDirector
Grant/Award
6,371$64.542,896(D)

View →

Mar 10, 2026Mar 12 9:20 PMStephanie OkeyDirector
Option Exercise
15,167$33.630(D)

View →

Feb 17, 2026Feb 19 10:25 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,813$25.6922,501(D)

View →